| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 181.534 | 196.518 | 220.863 | 229.708 | 243.700 | 269.369 | 282.535 | 315.924 | 347.943 | 457.261 |
| Total Income - EUR | 183.743 | 200.954 | 222.831 | 231.673 | 245.770 | 272.340 | 284.891 | 318.817 | 351.946 | 460.900 |
| Total Expenses - EUR | 177.965 | 202.715 | 225.782 | 222.691 | 230.361 | 253.474 | 266.757 | 306.324 | 340.657 | 446.481 |
| Gross Profit/Loss - EUR | 5.778 | -1.761 | -2.951 | 8.982 | 15.410 | 18.866 | 18.134 | 12.493 | 11.288 | 14.419 |
| Net Profit/Loss - EUR | 4.926 | -1.761 | -4.991 | 6.665 | 12.952 | 16.509 | 15.646 | 9.687 | 8.156 | 1.982 |
| Employees | 3 | 4 | 5 | 4 | 3 | 3 | 3 | 4 | 4 | 4 |
Check the financial reports for the company - Amenmina Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.234 | 4.072 | 3.710 | 3.414 | 3.060 | 2.841 | 3.256 | 2.963 | 2.590 | 2.515 |
| Current Assets | 46.058 | 56.564 | 51.210 | 51.839 | 79.237 | 93.062 | 117.396 | 122.244 | 127.105 | 158.220 |
| Inventories | 11.881 | 16.065 | 16.240 | 13.650 | 18.260 | 21.495 | 21.681 | 25.092 | 26.329 | 29.062 |
| Receivables | 16.683 | 7.158 | 27.810 | 29.627 | 27.772 | 36.071 | 37.823 | 39.903 | 45.699 | 46.162 |
| Cash | 17.494 | 33.341 | 7.159 | 8.562 | 33.205 | 35.496 | 57.892 | 57.249 | 55.078 | 82.996 |
| Shareholders Funds | 7.340 | 5.504 | 420 | 7.077 | 19.892 | 36.024 | 44.019 | 41.162 | 41.285 | 35.171 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 43.142 | 55.293 | 54.684 | 48.306 | 62.545 | 59.984 | 76.751 | 84.066 | 88.445 | 125.635 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Amenmina Pharm Srl